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BACKGROUND. Colorectal cancer (CRC) is a leading cause of cancer morbidity
and mortality for American Indians and Alaska Natives (AI/ANs), but misclassifi-
cation of race causes underestimates of disease burden.
METHODS. The authors compared regional differences in CRC incidence, stage at
diagnosis, and anatomic distribution between AI/ANs and non-Hispanic whites
(NHWs). To reduce misclassification, data from the National Program of Cancer
Registries; the Surveillance, Epidemiology, and End Results Program; and the In-
dian Health Service (IHS) were linked. The analysis was limited to the 56% of AI/
AN who live in IHS Contract Health Service Delivery Areas.
RESULTS. From 1999 to 2004, the overall incidence rate (per 100,000 persons per
year) of CRC was 9% lower in the AI/AN population (46.3) than in the NHW
population (50.8). However, AI/AN CRC incidence rates varied nearly 5-fold
regionally, from 21 in the Southwest to 102.6 in Alaska. Compared with NHW
rates, AI/AN rates were significantly higher in Alaska (rate ratio [RR], 2.03), the
Northern Plains (RR, 1.39), and the Southern Plains (RR, 1.16) but were lower in
the Pacific Coast (RR, 0.80), the East (RR, 0.65), and the Southwest (RR, 0.45). AI/
ANs were diagnosed more often with advanced CRC than with localized CRC
(RR, 1.92) compared with NHWs (RR, 1.48). Females more often had proximal
CRC among both the AI/AN population (females, 40.1%; males, 33.5%) and the
NHW population (females, 50.1%; males, 40.3%), although AI/ANs had a higher
proportion of distal cancers overall.
CONCLUSIONS. CRC incidence rates in AI/AN populations varied dramatically
between regions. Efforts are needed tomake CRC screening a priority, overcome bar-
riers to endoscopic screening, and to engage AI/AN communities in culturally
appropriate ways to participate in prevention and early detection programs. Cancer
2008;113(5 suppl):1179–90. Published 2008 by the American Cancer Society.*
KEYWORDS: colorectal cancer, epidemiology, incidence, Indians of North America,
health disparities, screening, colonic subsite, cancer stage.
C olorectal cancer (CRC) is a leading cause of cancer morbidityand mortality for American Indian and Alaska Native (AI/AN)
males and females.1-3 Although CRC mortality rates fell for most US
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populations from 1995 to 2004, there was no signifi-
cant change in AI/AN rates.2 It has been demon-
strated that CRC mortality varies significantly
between AI/AN populations living in different regions
of the US, with a >3-fold difference between the
Southwest and Alaska.1 AI/AN males and females, as
a group, reportedly have CRC incidence rates that
are lower than the US average; however, summary
measures may miss important rate heterogeneity
between AI/AN populations.4
Accurate determination of cancer burden is a
critical first step for addressing health disparities.
Race misclassification in medical records and on
death certificates makes determining cancer rates for
AI/AN populations difficult.5,6 Forthcoming data
from the National Longitudinal Mortality Survey cor-
relating self-identified race from Current Population
Surveys with information on death certificates indi-
cate that AI/ANs are classified as another race 44.8%
of the time.7 Such misclassification results in under-
estimates of both cancer incidence and mortality.8-11
The objective of the current analysis was to com-
pare regional CRC incidence rates by age, stage at di-
agnosis, and the colonic location of CRC tumors
between AI/AN and non-Hispanic white (NHW)
populations living in the same counties. This study is
part of a larger effort linking the Centers for Disease
Control and Prevention (CDC) National Program of
Cancer Registries (NPCR) database; the National
Cancer Institute (NCI) Surveillance, Epidemiology,
and End Result (SEER) database; and the Indian
Health Service (IHS) database to minimize the effects
of race misclassification on estimates of cancer inci-
dence.
MATERIALS AND METHODS
Data Sources
A more comprehensive description of the analytical
methods used for this and other articles in this sup-
plement of Cancer is published separately.12 We ana-
lyzed population-based cancer incidence data from
the NPCR and from the SEER Program.13,14 If data
from central cancer registries that provided permis-
sion for their use met quality criteria, then they were
included in the analysis (see footnote to Table 1 for a
list of registries). Population estimates from the US
Bureau of the Census, modified by the CDC and the
NCI, were used as denominators in the rate calcula-
tions.15,16 We included incident cases of invasive CRC
as detailed elsewhere.17 Data on disease stage
spanned changes in SEER Summary Stage coding.
Stage was coded according to the SEER Summary
Stage 1977 rules for diagnosis years 1999 through
2000 and SEER Summary Stage 2000 rules for diag-
nosis years 2001 through 2003; collaborative stage
data, which were reported first for 2004, were not
available for analysis. CRC stage data for 1999
through 2003 were combined for this analysis,
because the differences observed in comparative stu-
dies of the 2 systems were minimal.18,19 Tumor his-
tology was categorized as proposed by Berg20 and
modified by Stewart et al.21
To reduce the misclassification of AI/AN cases as
other races, all cancer case records from NPCR and
SEER registries were linked with IHS patient registra-
tion databases using a probabilistic linkage software
developed by the CDC.14 The IHS database identifies
all individuals who have ever accessed IHS services.
In addition, we focused on those AI/AN and NHW
populations that were living in counties where indivi-
duals were eligible for IHS contract care services,
called Contract Health Service Delivery Areas
(CHSDAs).
The 6 IHS regions used in this analysis (Alaska,
Pacific Coast, Northern Plains, Southern Plains,
Southwest, and East) and their constituent CHSDA
counties are shown in Figure 1. CHSDA counties, in
general, contain federally recognized tribal lands or
are adjacent to tribal lands. AI/AN males and females
must live within CHSDA boundaries and be mem-
bers of a federally recognized tribe to be eligible for
health services that are not available at IHS or tribal
health facilities. The proportions of the population
that are AI/AN relative to the total population are
higher in CHSDA counties than in non-CHSDA coun-
ties, and there is inherently less misclassification of
race in medical and death records.7 Overall, 56% of
AI/ANs live in CHSDA counties; however, this varies
by region (Alaska, 100%; East, 13.1%; Northern
Plains, 59%; Southern Plains, 64.1%; Pacific Coast,
55.6%; and Southwest, 87.5%).
Statistical Analyses
Two sets of statistics are provided for AI/AN and
NHW cancer cases: 1) data from all counties in the
respective regions (referred to as ‘All Counties’), and
2) data from all counties designated as CHSDA
(referred to as ‘CHSDA counties’). The results
described below refer to individuals who reside in
CHSDA counties unless otherwise noted.
The age groups for analysis (<40 years, 40-49
years, 50-64 years, and 65 years) were selected with
consideration of recommendations that average-risk
individuals begin CRC screening at age 50 years and
that screening colonoscopy coverage by Medicare,
which is available to most US citizens, begin at age
65 years.22,23 Anatomic subsites of incident cancers
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was divided into proximal (from the cecum to the
splenic flexure) and distal colon and rectum based
on International Classification of Diseases for Oncol-
ogy, Ninth Revision codes. Proximal includes the ce-
cum (C18.0), ascending colon (C18.2), hepatic flexure
(C 18.3), transverse colon (C18.4), and splenic flexure
(18.5); distal includes the descending colon (C18.6)
and sigmoid colon (C18.7); and rectum includes the
rectosigmoid junction (C19.9) and rectum (C20.9).
This convention was chosen because flexible sigmoi-
doscopy is capable of observing the distal 60 cm of
the colon to approximately the splenic flexure.
For all AI/AN and NHW populations, cancer inci-
dence rates were expressed per 100,000 persons per
year and were age-adjusted by 19 age groups
(<1 year, 1-4 years, 5-9 years, . . . , 80-84 years, 85
years) to the 2000 US standard population using the
direct method.13 Percent distributions for histology,
stage, and anatomic subsite also were age-adjusted
to the 2000 population. Ninety-five percent confidence
intervals (CIs) for age-adjusted rates were calculated
using the modification of Tiwari et al.24 Rate ratios
(RRs) were calculated as the age-adjusted incidence
rate for the AI/AN population of interest divided by the
age-adjusted incidence rate for the same-area NHW
population. The cancer incidence data were analyzed
using SEER*Stat software, version 6.3.6.25
RESULTS
Over the 6-year study period (1999 to 2004), there
were 3316 cases of invasive CRC diagnosed in the
All-Counties AI/AN population and 681,801 cases
diagnosed in the NHW population. Of these, 95.3%
of AI/AN cases and 96.5% of NHW cases were con-
firmed microscopically. Microscopically confirmed
cancers among AI/AN cases were 94.7% adenocarci-
nomas, 3% other specified carcinomas, 0.9% carcino-
mas not otherwise specified (NOS), 0.3% epidermoid
carcinomas, and 1.1% other histologic types. The cor-
responding percentages among NHW cases were
95.7%, 2%, 1.2%, 0.4%, and 0.7%, respectively. Signet
ring cell carcinomas accounted for 0.9% of microsco-
pically confirmed CRC cases among AI/ANs and
1.1% among NHWs.
Among AI/ANs with CRC, 79% (2621 individuals)
were residents of CHSDA counties compared with
21% (143,160) of NHWs (Table 1). The age-adjusted
CRC incidence rate among AI/ANs was 46.3 in
CHSDA counties and 33.9 in All Counties. CHSDA
AI/ANs had a 9% lower overall incidence rate of CRC
compared with the rate among CHSDA NHWs (RR,
0.91; 95% CI, 0.87-0.95). In contrast, the All-County
AI/AN incidence rate was 36% lower than the All
County NHW incidence rate. The remaining results
presented below are limited to residents of CHSDA
counties, because All-County data are likely underes-
timates because of misclassification of race not cor-
rected by our IHS linkage strategy.
Regional CHSDA incidence rates were signifi-
cantly higher in AI/ANs than NHWs in Alaska, the
Northern Plains, and the Southern Plains, whereas
the rates were significantly lower in the Pacific Coast,
East, and Southwest (Table 1). There was a nearly 5-
fold regional variation in incidence among AI/AN
populations (from 21.0 in the Southwest to 102.6 in
Alaska) compared with modest geographic variation
among NHW populations (from 46.8 in the South-
west to 55.2 in the East). The pattern of regional vari-
ation in incidence was apparent for both AI/AN
males and females. CRC incidence rates were consis-
tently higher among males with the exception of
Alaska and the East region. In Alaska, the AI/AN
female incidence rate of 106.2 was 2.6 times higher
than that of NHW Alaskan females and the highest of
any group in the analysis.
Stratifying by age (Tables 2 and 3) and among
those living in CHSDA counties, AI/AN populations
had comparable or slightly higher rates of CRC than
NHW populations (<40 years: RR, 1.25; 40-49 years:
RR, 1.05; 50-64 years: RR, 1.05). One exception was
that the overall CRC rate was significantly lower in
AI/ANs aged 65 years (RR, 0.84). Important regional
differences also were observed within and between
age strata: 9.5% of CRC cases occurred among AI/AN
males and females aged <50 years (the age for initi-
ating CRC screening among average-risk individuals)
compared with 7.9% of CRC cases among NHW indi-
viduals. Dramatically higher rates of CRC were
FIGURE 1. States and Contract Health Service Delivery Areas (CHSDA)
counties by Indian Health Service region.
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TABLE 2
Colorectal Cancer Invasive Incidence Rates and Percent Distribution by Age and Indian Health Service Region for American Indians/
Alaska Natives and Non-Hispanic Whites in Contract Health Service Delivery Area Counties: US, 1999-2004
IHS Region
<40 Years 40-49 Years 50-64 Years ‡65 Years
Count
% of
Casesa Rateb
95%
CI Count
% of
Casesa Rateb
95%
CI Count
% of
Casesa Rateb
95%
CI Count
% of
Casesa Rateb
95%
CI
AI/AN
Northern Plains 19 2.0 2.5 1.5-3.9 61 7.1 33.5c 25.7-43.1 175 24.5 118.3c 101.4-137.2 258 66.4 380.7c 334.3-431.7
Alaska 8 1.3 2.3 1.0-4.5 40 6.9 46.1c 32.9-62.8 128 26.9 183.8c 153.2-218.5 194 64.9 527.2c 453.6-609.5
Southern Plains 40 3.7 3.9 2.8-5.3 61 6.1 24.0 18.3-30.8 241 25.1 100.7c 88.3-114.2 430 65.1 309.9 281.1-340.9
Pacific Coast 16 1.8 1.2 0.7-2.0 42 5.1 12.9 9.3-17.5 161 23.5 60.8 51.7-70.9 245 69.5 212.9d 186.4-242.0
East 4 2.2 1.4 0.4-3.4 11 6.3 14.7 7.4-26.4 33 21.4 51.5d 35.4-72.4 64 70.1 199.7d 153.3-255.8
Southwest 38 6.0 2.2 1.6-3.0 48 9.0 12.2d 9.0-16.2 150 32.7 45.7d 38.7-53.7 154 52.3 86.9d 73.5-102.0
Total 125 2.8 2.3 1.9-2.7 263 6.7 20.0 17.7-22.6 888 25.8 79.6 74.5-85.1 1345 64.7 236.8d 224.1-250.0
NHW
Northern Plains 425 2.0 1.8 1.6-2.0 1361 5.4 18.3 17.4-19.3 5863 21.8 76.1 74.1-78.1 19,508 70.8 292.8 288.7-296.9
Alaska 36 2.7 2.3 1.6-3.2 73 4.3 14.0 11.0-17.7 276 18.9 63.8 56.4-71.9 483 74.2 296.9 270.4-325.2
Southern Plains 197 2.6 2.3 2.0-2.7 561 6.4 21.5 19.8-23.4 2452 23.6 81.4 78.2-84.7 7201 67.5 276.5 270.1-282.9
Pacific Coast 718 2.0 1.7 1.5-1.8 2477 5.7 18.1 17.4-18.8 10,319 22.1 71.4 70.0-72.8 32,816 70.2 269.9 267.0-272.8
East 587 2.2 2.1 1.9-2.3 1863 6.0 21.5 20.5-22.5 8167 23.1 85.2 83.4-87.1 27,404 68.7 300.1 296.5-303.7
Southwest 289 2.0 1.6 1.4-1.8 970 5.8 17.7 16.6-18.9 4674 22.7 70.8 68.8-72.9 14,440 69.5 257.2 253.0-261.5
Total 2252 2.1 1.8 1.8-1.9 7305 5.8 19.0 18.6-19.5 31,751 22.4 76.0 75.1-76.8 101,852 69.8 280.3 278.6-282.0
Source: Cancer registries in the Centers for Disease Control and Prevention’s National Program of Cancer Registries and/or the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program.
IHS indicates Indian Health Service; 95% CI, 95% confidence interval; AI/AN, American Indians/Alaska Natives; NHW, non-Hispanic whites.
aPercents may not add to 100% due to rounding.
bRates are per 100,000 persons and are age-adjusted to the 2000 US standard population (19 age groups; Census P25-1130).
cThe AI/AN rate is statistically significantly higher than the NHW rate (P < .05).
dThe AI/AN rate is statistically significantly lower than the NHW rate (P < .05).
Years of data and registries used: 1999-2004 (41 states and the District of Columbia): Alaska,* Alabama,* Arkansas, Arizona,* California,* Colorado,* Connecticut,* the District of Columbia, Delaware, Florida,*
Georgia, Hawaii, Iowa,* Idaho,* Illinois, Indiana,* Kentucky, Louisiana,* Massachusetts,* Maine,* Michigan,* Minnesota,* Missouri, Montana,* North Carolina,* Nebraska,* New Hampshire, New Jersey, New Mex-
ico,* Nevada,* New York,* Ohio, Oklahoma,* Oregon,* Pennsylvania,* Rhode Island,* Texas,* Utah,* Washington,* Wisconsin,* West Virginia, and Wyoming*; 1999 and 2002-2004: North Dakota*; 2001-2004: South
Dakota*; 2003-2004: Mississippi* and Virginia; 2004: Tennessee (asterisks indicate states with at least 1 county designated as a Contract Health Service Delivery Area).
TABLE 3
Colorectal Cancer Invasive Incidence Rates and Rate Ratios by Age and Indian Health Service Region for American Indians/
Alaska Natives and Non-Hispanic Whites in Contract Health Service Delivery Area Counties: US, 1999-2004
IHS Region
<40 Years 40-49 Years 50-64 Years ‡65 Years
AI/AN
Ratea
NHW
Ratea RR
95%
CI
AI/AN
Ratea
NHW
Ratea RR
95%
CI
AI/AN
Ratea
NHW
Ratea RR
95%
CI
AI/AN
Ratea
NHW
Ratea RR
95%
CI
Northern Plains 2.5 1.8 1.42 0.84-2.22 33.5 18.3 1.83b 1.39-2.37 118.3 76.1 1.55b 1.33-1.81 380.7 292.8 1.30b 1.14-1.48
Alaska 2.3 2.3 1.00 0.40-2.13 46.1 14.0 3.28b 2.17-4.89 183.8 63.8 2.88b 2.31-3.57 527.2 296.9 1.78b 1.49-2.11
Southern Plains 3.9 2.3 1.66b 1.15-2.34 24.0 21.5 1.11 0.84-1.45 100.7 81.4 1.24b 1.08-1.41 309.9 276.5 1.12b 1.01-1.24
Pacific Coast 1.2 1.7 0.73 0.42-1.20 12.9 18.1 0.72b 0.52-0.97 60.8 71.4 0.85b 0.72-1.00 212.9 269.9 0.79b 0.69-0.90
East 1.4 2.1 0.65 0.18-1.63 14.7 21.5 0.69 0.34-1.23 51.5 85.2 0.60b 0.42-0.85 199.7 300.1 0.67b 0.51-0.85
Southwest 2.2 1.6 1.39 0.96-1.94 12.2 17.7 0.69b 0.50-0.92 45.7 70.8 0.65b 0.55-0.76 86.9 257.2 0.34b 0.29-0.40
Total 2.3 1.8 1.25b 1.04-1.50 20.0 19.0 1.05 0.93-1.19 79.6 76.0 1.05 0.98-1.12 236.8 280.3 0.84b 0.80-0.89
Source: Cancer registries in the Centers for Disease Control and Prevention’s National Program of Cancer Registries and/or the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program.
IHS indicates Indian Health Service; AI/AN, American Indians/Alaska Natives; NHW, non-Hispanic whites; RR, rate ratio; 95% CI, 95% confidence interval.
aRates are per 100,000 persons and are age-adjusted to the 2000 US standard population (19 age groups; Census P25-1130).
bThe RR is statistically significant (P < .05).
Years of data and registries used: 1999-2004 (41 states and the District of Columbia): Alaska,* Alabama,* Arkansas, Arizona,* California,* Colorado,* Connecticut,* the District of Columbia, Delaware, Florida,*
Georgia, Hawaii, Iowa,* Idaho,* Illinois, Indiana,* Kentucky, Louisiana,* Massachusetts,* Maine,* Michigan,* Minnesota,* Missouri, Montana,* North Carolina,* Nebraska,* New Hampshire, New Jersey, New Mex-
ico,* Nevada,* New York,* Ohio, Oklahoma,* Oregon,* Pennsylvania,* Rhode Island,* Texas,* Utah,* Washington,* Wisconsin,* West Virginia, and Wyoming*; 1999 and 2002-2004: North Dakota*; 2001-2004: South
Dakota*; 2003-2004: Mississippi* and Virginia; 2004: Tennessee (asterisks indicate states with at least 1 county designated as a Contract Health Service Delivery Area).
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observed among AI/AN populations ages 40 to 49
years in Alaska (RR, 3.28) and the Northern Plains
(RR, 1.83). Although AI/ANs aged <50 years from the
Southwest had lower CRC rates relative to most other
regions, they accounted for 15% of Southwest AI/AN
cases. Similarly, AI/ANs aged <40 years in the South-
ern Plains accounted for 3.7% of cases and had a sig-
nificantly higher incidence of CRC than NHWs of
similar age (RR, 1.66).
In CHSDA counties, the overall rate of CRC
among AI/ANs ages 50 to 64 years was not signifi-
cantly different from that among NHWs (RR, 1.05),
although the RR ranged from 2.88 in Alaska to 0.60
in the East. The cohort aged 65 years accounted for
64.7% of CRC cases that occurred in the AI/AN
population and 69.8% of CRC cases that occurred in
the NHW population. Nationally, AI/ANs in this age
group had a lower rate of CRC (RR, 0.84;), although
the RR varied from 0.34 in the Southwest to 1.78 in
Alaska.
Data on disease stage at diagnosis were available
for the years 1999 through 2003. Eight percent were
unstaged among AI/ANs and 9.4% were unstaged
among NHWs. Among staged cancers, 66.5% of AI/
ANs were diagnosed at late-stage disease compared
with 59.6% of NHWs: AI/AN males and females were
more likely to have late-stage disease at diagnosis in
each region (Table 4). Overall, the RR for late-stage
versus early-stage CRC at diagnosis was 1.92 for AI/
ANs and 1.48 for NHWs. AI/AN males and females
TABLE 4
Invasive Colorectal Cancer Incidence Counts, Rates, and Rate Ratios by Stage, Indian Health Service Region, and Sex for American Indians
Alaska Natives and Non-Hispanic Whites in Contract Health Service Delivery Area Counties: US, 1999-2003
American Indians/Alaska Natives Non-Hispanic White
Early Stagea Late Stagea Late/Early Stagea Early Stagea Late Stagea Late/Early Stagea
IHS Region Sex Count Rateb Count Rateb RRc 95% CI for RR Count Rateb Count Rateb RRc 95% CI for RR
Northern Plains Both sexes 130 22.4 261 45.4 2.02 1.61-2.56 8226 19.2 12,472 29.2 1.52 1.48-1.56
Males 72 28.5 140 54.3 1.91 1.37-2.68 4186 22.5 6353 34.1 1.52 1.46-1.58
Females 58 18.3 121 38.4 2.11 1.51-2.97 4040 16.6 6119 25.3 1.52 1.46-1.58
Alaska Both sexes 112 38.7 176 60.0 1.55 1.20-2.01 270 19.4 396 28.2 1.46 1.23-1.73
Males 49 34.7 80 60.9 1.75 1.18-2.64 154 21.6 240 34.6 1.60 1.26-2.03
Females 63 41.2 96 60.0 1.46 1.04-2.05 116 17.0 156 22.3 1.32 1.02-1.71
Southern Plains Both sexes 195 18.9 371 34.8 1.85 1.54-2.22 3262 19.5 4861 29.2 1.50 1.43-1.56
Males 104 24.1 178 38.7 1.61 1.24-2.10 1750 24.4 2554 35.4 1.45 1.36-1.54
Females 91 15.2 193 32.2 2.11 1.64-2.75 1512 15.9 2307 24.4 1.54 1.44-1.64
Pacific Coast Both sexes 119 12.6 250 25.5 2.02 1.60-2.58 14,339 18.2 22,116 28.1 1.55 1.51-1.58
Males 57 14.3 126 28.7 2.00 1.41-2.90 7523 21.7 11,204 32.2 1.49 1.44-1.53
Females 62 11.5 124 23.3 2.02 1.46-2.83 6816 15.4 10,912 24.7 1.60 1.56-1.65
East Both sexes 25 10.4 62 25.0 2.41 1.48-4.10 12,049 21.2 16,338 28.8 1.36 1.33-1.39
Males 7 7.0 25 23.9 3.42 1.39-10.74 6281 26.0 8066 33.4 1.29 1.24-1.33
Females 18 13.0 37 26.2 2.01 1.12-3.80 5768 17.5 8272 25.2 1.44 1.39-1.49
Southwest Both sexes 84 5.7 198 12.5 2.19 1.68-2.90 5969 16.6 8979 25.1 1.51 1.47-1.57
Males 42 6.6 118 16.9 2.57 1.76-3.84 3295 20.1 4821 29.3 1.46 1.39-1.52
Females 42 5.1 80 9.1 1.79 1.21-2.70 2674 13.7 4158 21.4 1.57 1.49-1.65
Total Both sexes 665 14.7 1318 28.2 1.92 1.74-2.12 44,115 18.9 65,162 28.1 1.48 1.46-1.50
Males 331 16.8 667 32.1 1.91 1.65-2.21 23,189 22.8 33,238 32.6 1.43 1.41-1.46
Females 334 13.2 651 25.2 1.91 1.67-2.20 20,926 15.9 31,924 24.4 1.53 1.51-1.56
Source: Cancer registries in the Centers for Disease Control and Prevention’s National Program of Cancer Registries and/or the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Pro-
gram.
IHS indicates Indian Health Service; RR, rate ratio; 95% CI, 95% confidence interval.
aFor 1999-2000, SEER Summary Stage 1977 was used; for 2001-2003, SEER Summary Stage 2000 was used. Data for the 2 staging systems are combined because the differences observed in comparative analyses
were minimal (see Howe 200518 and Phillips 200319). Early stage includes local disease; late stage includes regional and distant stage disease.
bRates are per 100,000 persons and are age-adjusted to the 2000 US standard population (19 age groups; Census P25-1130). In situ cancers are excluded.
cAll RRs are statistically significant (P < .05).
Years of data and registries used: 1999-2004 (41 states and the District of Columbia): Alaska,* Alabama,* Arkansas, Arizona,* California,* Colorado,* Connecticut,* the District of Columbia, Delaware, Florida,*
Georgia, Hawaii, Iowa,* Idaho,* Illinois, Indiana,* Kentucky, Louisiana,* Massachusetts,* Maine,* Michigan,* Minnesota,* Missouri, Montana,* North Carolina,* Nebraska,* New Hampshire, New Jersey, New Mex-
ico,* Nevada,* New York,* Ohio, Oklahoma,* Oregon,* Pennsylvania,* Rhode Island,* Texas,* Utah,* Washington,* Wisconsin,* West Virginia, and Wyoming*; 1999 and 2002-2004: North Dakota*; 2001-2004: South
Dakota*; 2003-2004: Mississippi* and Virginia; 2004: Tennessee (asterisks indicate states with at least 1 county designated as a Contract Health Service Delivery Area).
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from Alaska were the least likely to have late-stage
CRC at diagnosis, whereas Eastern males and North-
ern and Southern Plains females were the most
likely.
Excluding the appendix, NOS subsites, and over-
lapping lesions, 36% of CRCs among AI/ANs were
located in the proximal portion (cecum to splenic
flexure) of the colon compared with 45.3% of CRCs
among NHW males and females from 1999 through
2004. The overall RR of proximal to distal (splenic
flexure through rectum) disease was lower among
AI/ANs than among NHWs, indicating a lower pro-
pensity toward proximal disease; the exceptions were
for both sexes in the East and among females in
Alaska, the Pacific Coast, and the Southwest, where
AI/AN rates of proximal and distal CRC were not sta-
tistically different (Table 5). Females were more likely
than males to be diagnosed with proximal disease
among both AI/ANs and NHWs (40.6% and 50.7%
among AI/AN and NHW females, respectively, com-
pared with 31.3% and 40.4% among AI/AN and NHW
males).
DISCUSSION
The objective of this study was to describe more
accurately the incidence of CRC in AI/AN popula-
tions by linking NPCR and SEER cancer registry data
with IHS records and then focusing on CHSDA coun-
ties where the misclassification of race was less pre-
TABLE 5
Invasive Colorectal Cancer Incidence Counts, Rates, and Rate Ratios by Tumor Location, Indian Health Service Region, and Sex for
American Indians/Alaska Natives and Non-Hispanic Whites in Contract Health Service Delivery Area Counties: US, 1999-2004a
American Indians/Alaska Natives Non-Hispanic Whites
Proximal
Distal and
Rectum
Proximal/Distal and
Rectum Proximal
Distal and
Rectum
Proximal/Distal and
Rectum
IHS Region Sex Count Rateb Count Rateb RR 95% CI for RR Count Rateb Count Rateb RR 95% CI for RR
Northern Plains Both sexes 156 22.5 324 44.1 0.51c 0.41-0.63 11,755 22.4 13,431 26.1 0.86c 0.84-0.88
Males 77 25.7 181 53.7 0.48c 0.35-0.65 5251 23.7 7618 33.3 0.71c 0.69-0.74
Females 79 20.3 143 36.2 0.56c 0.42-0.75 6504 21.5 5813 20.2 1.06c 1.02-1.10
Alaska Both sexes 141 42.0 211 56.2 0.75c 0.59-0.94 326 21.1 485 26.3 0.80c 0.69-0.93
Males 52 33.9 105 61.3 0.55c 0.38-0.80 177 23.5 307 33.8 0.70c 0.56-0.86
Females 89 49.0 106 51.7 0.95 0.70-1.27 149 18.9 178 19.3 0.98 0.77-1.24
Southern Plains Both sexes 237 19.4 429 32.1 0.60c 0.51-0.71 3947 19.5 5292 26.5 0.74c 0.71-0.77
Males 109 22.0 215 37.4 0.59c 0.46-0.75 1840 21.6 3041 34.6 0.62c 0.59-0.66
Females 128 17.9 214 28.6 0.63c 0.50-0.79 2107 17.9 2251 20.3 0.89c 0.83-0.94
Pacific Coast Both sexes 166 15.3 281 21.5 0.71c 0.58-0.88 20,161 21.0 23,515 24.9 0.84c 0.83-0.86
Males 69 15.2 153 26.2 0.58c 0.42-0.79 9174 22.2 13,315 31.3 0.71c 0.69-0.73
Females 97 15.8 128 17.7 0.89 0.67-1.18 10,987 20.0 10,200 19.6 1.02 1.00-1.05
East Both sexes 45 15.7 64 19.5 0.80 0.53-1.20 15,890 22.5 19,726 29.2 0.77c 0.76-0.79
Males 16 12.2 28 18.9 0.64 0.31-1.28 7236 25.0 10,762 36.7 0.68c 0.66-0.70
Females 29 18.0 36 20.2 0.89 0.52-1.50 8654 20.8 8964 23.4 0.89c 0.86-0.92
Southwest Both sexes 123 7.0 237 12.1 0.58c 0.46-0.73 8289 18.9 10,341 23.8 0.80c 0.77-0.82
Males 52 7.0 142 16.4 0.43c 0.30-0.60 4076 20.8 5973 29.6 0.70c 0.68-0.73
Females 71 7.1 95 8.7 0.81 0.58-1.12 4213 17.4 4368 18.8 0.92c 0.89-0.97
Total Both sexes 868 16.3 1546 25.9 0.63c 0.58-0.69 60,368 21.2 72,790 26.1 0.81c 0.80-0.82
Males 375 16.6 824 31.0 0.53c 0.47-0.61 27,754 22.9 41,016 32.9 0.69c 0.68-0.71
Females 493 16.3 722 22.0 0.74c 0.66-0.84 32,614 19.9 31,774 20.5 0.97c 0.95-0.98
Source: Cancer registries in the Center for Disease Control and Prevention’s National Program of Cancer Registries and/or the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Pro-
gram.
IHS indicates Indian Health Service; RR, rate ratio; 95% CI, 95% confidence interval.
a Rates are per 100,000 persons and are age-adjusted to the 2000 US standard population (19 age groups; Census P25-1130). Excludes in situ cancers.
b The RR is statistically significant (P < .05).
Years of data and registries used: 1999-2004 (41 states and the District of Columbia): Alaska,* Alabama,* Arkansas, Arizona,* California,* Colorado,* Connecticut,* the District of Columbia, Delaware, Florida,*
Georgia, Hawaii, Iowa,* Idaho,* Illinois, Indiana,* Kentucky, Louisiana,* Massachusetts,* Maine,* Michigan,* Minnesota,* Missouri, Montana,* North Carolina,* Nebraska,* New Hampshire, New Jersey, New Mex-
ico,* Nevada,* New York,* Ohio, Oklahoma,* Oregon,* Pennsylvania,* Rhode Island,* Texas,* Utah,* Washington,* Wisconsin,* West Virginia, and Wyoming*; 1999 and 2002-2004: North Dakota*; 2001-2004: South
Dakota*; 2003-2004: Mississippi* and Virginia; 2004: Tennessee (asterisks indicate states with at least 1 county designated as a Contract Health Service Delivery Area).
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valent. During the study period, CRC was the third
most commonly diagnosed cancer among CHSDA
AI/AN males and females, accounting for 11.8% of all
cancers.26 Our most dramatic finding was the re-
gional variation in CRC incidence, with an almost 5-
fold difference observed between AI/AN populations
in Alaska and the Southwest. Also important were
differences in incidence, stage of diagnosis, and colo-
nic subsite distribution between AI/AN and NHW
populations. Because only 56% of AI/ANs live in
CHSDA counties (15% in the East Region), caution
should be exercised not to generalize our results to
the entire AI/AN population.
Geographic, racial, and gender differences in
both CRC incidence and the distribution of incident
cancers by colonic subsite may provide insights into
etiologic risk factors and are important for guiding
CRC screening recommendations. Regional differ-
ences in CRC incidence are likely a function of the
heterogeneity of AI/AN populations, which vary
greatly in culture, diet, resources, environment, and,
theoretically, even genetic risk. Regional data from
the Behavioral Risk Factor Surveillance System
(BRFSS) suggest that AI/AN males and females have
a higher prevalence of known CRC risk factors,
including diabetes, obesity, smoking, and binge alco-
hol consumption.27 Except for smoking, however, re-
gional variations of these risk factors do not appear
to mirror regional differences in CRC incidence rates.
Smoking rates during 1999 through 2003 for South-
west AI/ANs (20.4%) were less than 50% of those
reported in the Northern Plains and Alaska (both
43.9%).
Regional differences in diet and environmental
micronutrients also may modify CRC risk.28,29 For
example, previous studies have suggested that solar
irradiance and its role in vitamin D production may
explain in part the North-South CRC incidence gradi-
ent observed in the general population.30,31 It also is
believed that calcium intake decreases CRC risk, and
calcium is plentiful in the ground water of the Nav-
ajo reservation.32,33 Other population differences that
also may alter the risk of CRC include the dietary
intake of animal fats, folate, and the consumption
patterns of fresh produce.34-37
In several areas, AI/ANs appeared to be suscepti-
ble to CRC at younger ages than NHWs. During the
study period, there were 40 cases of CRC in
the Southern Plains that occurred in AI/ANs aged
<40 years, a rate 66% higher than that for NHWs in
this age group. Significantly higher rates of CRC also
were observed among AI/ANs ages 40 to 49 years in
Alaska and the Northern Plains. The onset of CRC in
young populations should raise suspicion for the
presence of hereditary CRC syndromes. Indeed, Nav-
ajo kindreds with hereditary nonpolyposis CRC syn-
drome have been followed for decades.38 Further
work is needed in these populations to elucidate
CRC risk factors and to assess whether CRC screen-
ing recommendations should be modified to include
younger individuals.
Regional differences in CRC screening also may
affect incidence. It is believed that screening pri-
marily is responsible for the declining rate of CRC
in the general population while it also contributes
to a shift toward earlier stages of disease at diagno-
sis.22,39 Flexible sigmoidoscopy screening also has
been implicated in a temporal shift of incident
CRCs from the distal colon and rectum to more
proximal sites.40-43 Although BRFSS data suggest
that AI/ANs have lower CRC fecal occult blood test-
ing (FOBT) and endoscopic screening rates than
NHWs (overall, 44.0% and 53.8%, respectively),27 the
true screening disparity may be far greater. Partici-
pation in the BRFSS requires individuals have a tele-
phone and be willing to be interviewed.44 For AI/
ANs, this tends to select those with more income,
higher levels of education, and less traditional ways
of life, all of which have been associated with higher
rates of screening participation.8,45,46 In addition,
cultural factors, including a reluctance to trust out-
siders, modesty, and hesitancy to discuss one’s
health, may bias BRFSS prevalence estimates further
for AI/ANs.
Data from other sources suggest significant vari-
ation in screening rates between AI/ANs and NHWs.
For example, a 2007 review of CRC screening compli-
ance among patients who visited Alaska tribal health
centers reported that 34.8% of individuals aged 50
years were current with U.S. Preventive Services Task
Force CRC screening recommendations, although
rates from individual tribal health facilities ranged
from 5.5% to 60.8%.47 This compares with a reported
Alaska AI/AN BRFSS rate of 49.5%.27 Although finan-
cial, institutional, geographic, and cultural barriers to
CRC screening vary widely between communities,
AI/ANs in the Southwest and Northern Plains are sig-
nificantly less likely than the general population to
have undergone CRC screening.48,49 Poverty, low edu-
cation attainment, and insufficient health coverage
are major challenges for AI/AN communities and
also most likely contribute to lower screening
rates.50-52
The colonic subsite distribution of CRC has
major relevance for the choice of methods used for
screening. For example, prior reports have demon-
strated that females in the US have a higher preva-
lence of adenomatous polyps and CRCs in the
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proximal colon than men, leading to conclusions
that colonoscopy is a preferable CRC screening
option for females.42,53 Our work also indicated that
females had a greater propensity toward proximal
CRC. NHW females had a near equal prevalence of
proximal to distal cancers, whereas NHW males had
proportionally fewer proximal cancers. Similarly, AI/
AN females had a higher proportion of proximal can-
cers than AI/AN men. However, as a population, AI/
ANs had proportionately more distal cancers (64%)
than NHWs (55%). Factors other than gender that are
believed to influence subsite distribution include
smoking, physical activity, alcohol abuse, diabetes,
nonsteroidal anti-inflammatory drug use, and dietary
factors.40,54-63 A better understanding of the relative
risks of these variables and CRC in AI/AN popula-
tions is needed.
Our analysis revealed that AI/ANs were diag-
nosed more commonly with later stage CRC than
NHWs. Many factors influence the stage at which
CRC is diagnosed. AI/AN communities face substan-
tial barriers to the early detection and prevention of
CRC. Limited availability of endoscopic services, pro-
vider time pressures, health systems that are geared
and used primarily for acute and subacute care, and
an underfunded health system are institutional bar-
riers to screening for many AI/AN healthcare sys-
tems. In addition, cultural hesitance to access
Western medicine for nonacute health problems,
infrequent provider recommendations to get
screened, insufficient health coverage, inability to
afford Medicare or insurance copays, and transporta-
tion difficulties are factors commonly cited as cancer
screening barriers by AI/AN individuals.46,64-66
Alaska, although it has the highest AI/AN popu-
lation CRC rates, had the highest proportion of cases
detected in early stages. Among IHS regions, Alaska
has been the most proactive toward CRC screening.
Since 2000, Alaska has increased its CRC screening
rate by >50%.47 Vanguard efforts have included the
training and employment of a nurse practitioner who
conducts screening colonoscopies in Anchorage and
programs to train mid-level providers to conduct
flexible sigmoidoscopies at regional health facil-
ities.67,68 Innovation has been spurred by the CRC
burden as well as by the necessary abandonment of
guaiac-based FOBT because of a high prevalence of
Helicobacter pylori-associated hemorrhagic gastritis.69
The commitment of the Alaska Native Tribal Health
Consortium to increasing endoscopic capacity, over-
come cost and transportation barriers, and the
implementation of screening promotion programs
are having a positive impact on disease stage at diag-
nosis.
In our study, CRC incidence rates appeared to be
much higher among AI/AN males and females living
in CHSDA counties than in all counties. This differ-
ence is most likely because of higher rates of race
misclassification in non-CHSDA areas that are not
corrected by our linkage rather than true differences
in incidence. In 2000, 64.1% of the AI/AN population
lived outside of Census Bureau-defined ‘American In-
dian areas,’ and >31% were not considered part of
the IHS population.70,71 Data on the health status of
these mostly urban AI/AN populations are scarce
and resources are fleeting, with only 1% of the an-
nual IHS appropriation available to support 34 urban
AI/AN clinics across the nation. More work to define
and address the health of urban AI/AN populations
clearly is needed.
For this study, linkages and geographic analyses
were used to reduce the misclassification of race in
AI/AN populations to more accurately describe CRC
incidence. Clearly, there are significant regional dif-
ferences in CRC rates among AI/AN males and
females. Work to understand the reasons behind this
5-fold variation holds great promise for elucidating
CRC risk factors, not only for AI/AN populations but
for all populations. Our findings that AI/AN tend to
be diagnosed with more advanced disease, coupled
with the apparent success of Alaskan endoscopic
screening programs in capturing earlier stage diag-
noses, call for resources and diligence in approach-
ing this disparity. Currently, approximately 1 in 18
Americans will be diagnosed with CRC in their life-
time.72 The lifetime risk for AI/AN males and females
in Alaska and the Northern and Southern Plains is
higher. Although efforts aimed at modifying CRC risk
factors are important, they are often a generational
objective. Meanwhile, up to 90% of CRC can be pre-
vented by screening and surveillance because of the
efficacy of removing adenomatous polyps before
they become cancers.43,73 Disparities in CRC inci-
dence and stage at diagnosis are likely to persist until
screening is made a priority for tribal health systems,
the many barriers to screening are overcome, and
AI/AN communities are engaged in culturally appro-
priate ways to participate.
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